Study identifier:4522IL/0053
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A Single Centre, Randomised, Double-blind, 2-way Crossover Trial to Assess the Effect of Itraconazole, a CYP3A4 Inhibitor, on the Pharmacokinetics of a Single Dose of ZD4522 80 mg in Healthy Male Volunteers
hypercholesterolaemia
N/A
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|